Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Disease area: Respiratory critical care, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Simona Soresi (Isleworth, United Kingdom), Neeraj Kohli, Kirsty Habibi-Parker, Haifa Lyster, Anna K. Reed, Martin Carby, Andre R. Simon, Aron F. Popov, Simona Soresi. LATE-BREAKING ABSTRACT: Challenging immunosuppression treatment in lung transplant patients with kidney failure: Rescue therapy with basiliximab?. Eur Respir J 2015; 46: Suppl. 59, 1786

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Long-term survival with extracorporeal photochemotherapy in lung transplant rejection patients not responsive to conventional treatment. Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Initial treatment with CsA-AZA versus FK506-MPA: Comparison of early outcomes after lung transplantation Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation Source: Eur Respir J 2001; 18: Suppl. 33, 298s Year: 2001 Aerosolized liposomal cyclosporine A for treatment of progressive allograft dysfunction following lung transplantation Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 The influence of different immunosuppressive regimen on non-mnestic cognitive functions in patients after lung transplantation Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues Year: 2014 Negative consequences of immunosuppressive therapy on bronchial healing following lung transplantation (LTx) Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Azathioprine discontinuation and medium and long term outcomes after lung transplantation Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016 Hypogammaglobulinemia in lung transplant candidates Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 LATE-BREAKING ABSTRACT: Prospective randomised pilot study to investigate the clinical effect of orally inhaled AP301 on treatment of primary graft dysfunction (PGD) in patients after primary lung transplantation (LuTX) Source: International Congress 2015 – Predictors of lung transplant complications Year: 2015 Immunosuppressive therapy after human lung transplantation Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=105 Year: 2003 Infectious complications after lung transplantation Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=193 Year: 2003 The effect of everolimus on lung function and renal status in lung transplanted patients Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Treatment options in chronic GVHD and CLAD post lung transplantation Source: International Congress 2016 – Chronic graft-versus-host disease and chronic allograft dysfunction after lung transplantation: similarities and dissimilarities Year: 2016 Respiratory and renal functional evolutionary profiles after introduction of everolimus and minimizing doses of calcineurin inhibitors in lung transplant recipients, a descriptive observational study Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 Immunosuppressive therapy after human lung transplantation Source: Eur Respir J 2004; 23: 159-171 Year: 2004 Effects of two immunosuppressive triple therapies on inflammatory cells in lung Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Everolimus as a treatment of Chronic Lung Alograft Rejection (CLAD) in lung transplantation. Source: International Congress 2019 – Lung transplantation: from bench to bedside Year: 2019 Effects of basiliximab and triple therapy on airway mucociliary clearance of rats Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Early sirolimus immunosuppression is safe in lung transplantation Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012